ArticleESMO open2025

Efficacy of pembrolizumab in microsatellite-stable, tumor mutational burden-high metastatic colorectal cancer: genomic signatures and clinical outcomes.

K Yamaguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.